Weyland Pharmaceuticals Division
GPTKB entity
Statements (61)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquired |
gptkb:Gen_Tech_Labs
|
| gptkbp:ceo |
gptkb:Dr._Elizabeth_Weyland
|
| gptkbp:collaborates_with |
various universities
|
| gptkbp:depicted_in |
gptkb:NASDAQ
|
| gptkbp:employs |
5000 people
|
| gptkbp:focuses_on |
gptkb:Company
|
| gptkbp:founded |
gptkb:2020
|
| gptkbp:has_part |
gptkb:hospital
gptkb:Police_Department gptkb:Research_Institute customer service department finance department sales department business development team marketing department quality assurance team human resources department legal department clinical trials division environmental health and safety team regulatory affairs team strategic planning team supply chain management team sustainability team corporate communications team data analytics team biostatistics team research ethics board product management team clinical data management team clinical operations team clinical research organization clinical pharmacology team regulatory compliance team supply chain optimization team product safety team patient advocacy team medical affairs team clinical supply team pharmacovigilance team patient safety team market access team therapeutic area teams medical writing team partnerships and alliances team global health initiatives team |
| gptkbp:headquarters |
gptkb:Los_Angeles
|
| https://www.w3.org/2000/01/rdf-schema#label |
Weyland Pharmaceuticals Division
|
| gptkbp:is_known_for |
innovative drug solutions
|
| gptkbp:operates_in |
gptkb:North_America
|
| gptkbp:part_of |
gptkb:Weyland_Corp
|
| gptkbp:produced_by |
medications
|
| gptkbp:product_line |
gptkb:physicist
antibiotics vaccines |
| gptkbp:research_focus |
gptkb:healthcare_organization
|
| gptkbp:revenue |
1 billion USD
|
| gptkbp:subsidiary |
Weyland Biotech
|
| gptkbp:bfsParent |
gptkb:Weyland_Corporation
|
| gptkbp:bfsLayer |
5
|